Evaxion A (EVAX) Interest Expenses (2020 - 2026)
Evaxion A (EVAX) posted Interest Expenses of -$332000.0 for Q1 2026, up 87.92% on a QoQ basis from -$2.7 million in Q4 2025, and up 16.37% year-over-year from -$285290.0 in Q1 2025.
Evaxion A (EVAX) Interest Expenses (2020 - 2026) Analysis & Trends
Evaxion A's Interest Expenses history runs 7 years deep, the most recent figure standing at -$332000.0 for Q1 2026.
- Quarterly Interest Expenses rose 16.37% year-over-year to -$332000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.9 million (down 111.85% YoY) and the FY2025 annual result came in at -$5.7 million, down 83.67% from the prior year.
- Interest Expenses was -$332000.0 for Q1 2026 at Evaxion A, up from -$2.7 million in the prior quarter.
- Across five years, Interest Expenses topped out at -$158000.0 in Q1 2022 and bottomed at -$2.7 million in Q4 2025.
- A 5-year average of -$802823.5 and a median of -$397000.0 in 2025 frame the typical range for Interest Expenses.
- Peak annual rise in Interest Expenses reached 71.59% in 2022, while the deepest fall reached 719.44% in 2022.
- Evaxion A's Interest Expenses stood at -$590000.0 in 2022, then tumbled by 51.69% to -$895000.0 in 2023, then jumped by 48.83% to -$458000.0 in 2024, then sank by 500.0% to -$2.7 million in 2025, then surged by 87.92% to -$332000.0 in 2026.
- Business Quant data shows EVAX's Interest Expenses at -$332000.0 in Q1 2026, -$2.7 million in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - | -332,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -332,000.00 |
| Mar 31, 2026 | -332,000.00 |
| Dec 31, 2025 | -2.75 Mn |
| Dec 31, 2025 | -2.75 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Mar 31, 2025 | -397,000.00 |
| Mar 31, 2025 | -397,000.00 |
| Dec 31, 2024 | -458,000.00 |
| Dec 31, 2024 | -458,000.00 |
| Sep 30, 2024 | -384,000.00 |
| Sep 30, 2024 | -384,000.00 |
| Jun 30, 2024 | -2.04 Mn |
| Jun 30, 2024 | -2.04 Mn |
| Mar 31, 2024 | -246,000.00 |
| Mar 31, 2024 | -246,000.00 |
| Dec 31, 2023 | -895,000.00 |
| Dec 31, 2023 | -895,000.00 |